102 related articles for article (PubMed ID: 10436533)
1. [Factor XIII: experimental and clinical results in diabetic foot ulcer].
Wozniak G; Noll T; Bott U; Hehrlein FW
Zentralbl Chir; 1999; 124 Suppl 1():73-7. PubMed ID: 10436533
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms influencing cellular physiology as a concept of treatment for wound healing disturbances].
Wozniak G; Noll T
Zentralbl Chir; 2005 Dec; 130(6):526-33. PubMed ID: 16382399
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
Wozniak G; Dapper F; Alemany J
Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability.
Wozniak G; Noll T; Brunner U; Hehrlein FW
Vasa; 1999 Aug; 28(3):160-3. PubMed ID: 10483319
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of various growth factors on the improvement of impaired healing ulcers in patients with diabetic disease].
Feng J; Du WH; Wang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):273-7. PubMed ID: 12080817
[TBL] [Abstract][Full Text] [Related]
6. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases.
Generini S; Tuveri MA; Matucci Cerinic M; Mastinu F; Manni L; Aloe L
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):542-4. PubMed ID: 15505764
[TBL] [Abstract][Full Text] [Related]
7. M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds.
Beckert S; Pietsch AM; Küper M; Wicke C; Witte M; Königsrainer A; Coerper S
Ann Surg; 2009 Apr; 249(4):677-81. PubMed ID: 19300218
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
[TBL] [Abstract][Full Text] [Related]
9. [Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study].
Mishima Y; Nagao F; Ishibiki K; Matsuda M; Nakamura N
Chirurg; 1984 Dec; 55(12):803-8. PubMed ID: 6394228
[TBL] [Abstract][Full Text] [Related]
10. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
11. Morphometric analysis of skin microvasculature in the diabetic foot.
Yusof MI; Al-Astani AD; Jaafar H; Rashid FA
Singapore Med J; 2008 Feb; 49(2):100-4. PubMed ID: 18301834
[TBL] [Abstract][Full Text] [Related]
12. Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient.
Humpert PM; Bärtsch U; Konrade I; Hammes HP; Morcos M; Kasper M; Bierhaus A; Nawroth PP
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):538-40. PubMed ID: 16235157
[TBL] [Abstract][Full Text] [Related]
13. Healing of diabetic foot ulcers in L-arginine-treated patients.
Arana V; Paz Y; González A; Méndez V; Méndez JD
Biomed Pharmacother; 2004 Dec; 58(10):588-97. PubMed ID: 15589068
[TBL] [Abstract][Full Text] [Related]
14. The effect of fibrin stabilizing factor (F.XIII) on healing of bone defects in normal and uncontrolled diabetic rats.
el-Hakim IE
Int J Oral Maxillofac Surg; 1999 Aug; 28(4):304-8. PubMed ID: 10416901
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
Jude EB; Apelqvist J; Spraul M; Martini J;
Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
[TBL] [Abstract][Full Text] [Related]
16. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers.
Moustafa M; Simpson C; Glover M; Dawson RA; Tesfaye S; Creagh FM; Haddow D; Short R; Heller S; MacNeil S
Diabet Med; 2004 Jul; 21(7):786-9. PubMed ID: 15209775
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells and basic fibroblast growth factor.
Asai J; Takenaka H; Ichihashi K; Ueda E; Katoh N; Kishimoto S
J Dermatol; 2006 May; 33(5):349-52. PubMed ID: 16700668
[TBL] [Abstract][Full Text] [Related]
18. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
Zimny S; Schatz H; Pfohl M
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the burn wound and diabetic ulcer wound].
Lin C; Qiao L; Zhang P; Chen GX; Xu JJ; Yang N; Lu SL
Zhonghua Shao Shang Za Zhi; 2007 Oct; 23(5):339-41. PubMed ID: 18396758
[TBL] [Abstract][Full Text] [Related]
20. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
